Clinical Trials on Primary Ciliary Dyskinesia

Total 64449 results

Yu-Li Hospital

Unknown

The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial

Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome

Taiwan
Herzog Hospital

Unknown

D-Serine Treatment For Tardive Dyskinesia

Tardive Dyskinesia | Schizophrenia and Schizoaffective Disorder

Israel
University of Valencia
Hospital Universitario La Fe; Hospital General Universitario de Valencia; Hospital...

Completed

Intervention in Chronic Pediatric Patients and Their Families. (FACTORADAPT)

Asthma | Type 1 Diabetes | Allergic Rhinitis | Cystic Fibrosis | Pulmonary Disease | Atopic Dermatitis | Food Allergy | Allergic Asthma | Rhinoconjunctivitis | Primary Ciliary Dyskinesia | Short Stature

Spain
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction

Sphincter of Oddi Dysfunction

China
University Health Network, Toronto

Unknown

Family Studies in Primary Biliary Cirrhosis (PBC)

Biliary Cirrhosis, Primary

Canada
Lama Saad El-Din Mahmoud

Completed

the Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Spastic Stroke Patient. The Patients Were Diagnosed With the Lateral Scapular Slide Test, Fugl-Meyer Upper Extremity (FMUE) Scale Scores & Scapular Balance Angle Test (SBA).

Post Stroke Scapular Dyskinesia

Egypt
University Hospital, Montpellier

Terminated

Validation of the Implantation of a New Electrode for the Treatment of Dystonia (MONOCONTACT)

Tardive Dystonia | Generalized Dystonia | Segmental Dystonia

France
University of Aarhus
Aarhus University Hospital; Hvidovre University Hospital

Recruiting

Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

Denmark
CymaBay Therapeutics, Inc.

Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

United States, Korea, Republic of, Belgium, Spain, France, Switzerland, Romania, United Kingdom, Austria, Israel, Australia, Argentina, Canada, Chile, Germany, Greece, Hungary, Italy, Mexico, Netherlands, Poland, Czechia, New Zealand, Turke... and more
Target PharmaSolutions, Inc.

Active, not recruiting

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Biliary Cirrhosis, Primary

United States
National Taiwan University Hospital

Completed

Scapular Dyskinesis: a Reliability and Validity Study of Comprehensive Classification Test

Unilateral Shoulder Pain With and Without Scapular Dyskinesis

Taiwan
Zydus Therapeutics Inc.

Completed

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis (EPICS)

Primary Biliary Cirrhosis

United States
CymaBay Therapeutics, Inc.

Completed

Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

United States, Germany, United Kingdom, Canada
Calliditas Therapeutics AB

Completed

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

Primary Biliary Cirrhosis

United States, Israel, Belgium, Germany, United Kingdom, Spain, Greece, Canada, Italy
Sun Yat-sen University

Unknown

Probiotics in PBC Patients of Poor Response to UDCA

Primary Biliary Cholangitis (PBC)

China
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Effect of the Visual Information Change in Functional Dystonia (PRISMADYS)

Central Nervous System Diseases | Nervous System Diseases | Neurologic Manifestations | Movement Disorders | Dyskinesias | Dystonia | Dystonic Disorders | Torticollis

France
Ipsen

Active, not recruiting

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)

Primary Biliary Cirrhosis

United States, France, Spain, Belgium, Germany, Switzerland, Brazil, United Kingdom, Argentina, Canada, Chile, Italy, South Africa, Turkey
Instituto Mexicano del Seguro Social

Active, not recruiting

A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis

Primary Biliary Cirrhosis

Mexico
Ipsen

Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (ELFIDENCE)

Primary Biliary Cholangitis (PBC)

United States, Spain, France, Korea, Republic of, Italy, Czechia, Poland, Romania
Genfit

Completed

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cholangitis (PBC)

United States, United Kingdom, France, Germany, Spain
CymaBay Therapeutics, Inc.

Terminated

Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis (PBC)

Germany, United States, Canada, United Kingdom, Poland
Cascade Pharmaceuticals, Inc

Recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Primary Biliary Cholangitis (PBC)

China
Humanity and Health Research Centre
Beijing 302 Hospital

Recruiting

Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid

Primary Biliary Cholangitis (PBC)

China
Xijing Hospital of Digestive Diseases

Unknown

Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis

Primary Biliary Cirrhosis

China
HighTide Biopharma Pty Ltd

Completed

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis (PRONTO-PBC)

Biliary Tract Diseases | Cholangitis | Cholestasis | Primary Biliary Cholangitis | Primary Biliary Cirrhosis | Bile Duct Stricture

United States
University of Alberta

Completed

Mind-body Wellness Intervention in Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

Canada
Kiminori Kimura, MD
Japan Agency for Medical Research and Development; Ohara Pharmaceutical Co....

Completed

Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)

Liver Cirrhosis, Biliary | Primary Biliary Cholangitis (PBC)

Japan
University of Alberta

Completed

Online Wellness Intervention for Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

Canada
Teikyo University

Completed

Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis

Primary Biliary Cirrhosis

Japan
University of California, San Diego
National Institute of Mental Health (NIMH)

Completed

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

Dyskinesia, Drug-Induced

United States
Adamas Pharmaceuticals, Inc.

Completed

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) (EASED)

Parkinson's Disease | Dyskinesia | Levodopa Induced Dyskinesia

United States
Bukwang Pharmaceutical
Contera Pharma ApS

Completed

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia (LID)

Parkinson's Disease | Levodopa Induced Dyskinesia (LID)

South Africa
Corporal Michael J. Crescenz VA Medical Center

Unknown

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Schizophrenia | Schizoaffective Disorder | Tobacco Smoking | Tardive Dyskinesia | Parkinsonism

United States
University of Arizona
Scott Richards

Active, not recruiting

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

Parkinson's Disease | Levodopa-Induced Dyskinesia

United States
Wisconsin Center for Advanced Research
Aurora Health Care

Terminated

Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction

Abdominal Pain | Sphincter of Oddi Dysfunction

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease

Kartagener Syndrome

United States
University Hospital, Montpellier

Recruiting

Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation (DBS-QoLs)

Dystono-dyskinetic Syndromes

France
Sumitomo Pharma Co., Ltd.

Completed

A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease

Parkinson's Disease | Levodopa-induced Dyskinesia

Japan
Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID (ALLAY-LID-II)

Parkinson's Disease | Levodopa Induced Dyskinesia (LID)

France, Germany, Canada, United States, Spain
Adamas Pharmaceuticals, Inc.

Completed

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) (EASE LID)

Parkinson's Disease | Dyskinesia | Levodopa Induced Dyskinesia (LID)

United States, Canada
Novartis

Completed

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

Parkinson's Disease | L-dopa Induced Dyskinesia

Germany
1st Hospital of Social Security Services
UCB Pharma

Unknown

Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease

Levodopa Induced Dyskinesia

Greece
Neurocrine Biosciences

Recruiting

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Tardive Dyskinesia | Major Depressive Disorder

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease

Cystic Fibrosis | Chronic Granulomatous Disease | Primary Ciliary Dyskinesia | Pseudohypoaldosteronism | Nontuberculous Mycobacterial Infection

United States
Danish Research Centre for Magnetic Resonance
Bispebjerg Hospital

Recruiting

Dynamic Brain Mapping of the Functional Effects of Levodopa on Multiple Cortex-basal Ganglia Circuits in Parkinson ́s Disease (Dyn-fMRI-PD)

Levodopa-induced Dyskinesia in Parkinson's Disease

Denmark
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

China
Lawson Health Research Institute
Imperial College London; Queen's University; Northern Ontario School of Medicine

Completed

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Obesity | Schizophrenia | Schizoaffective Disorder | Insulin Resistance | Tardive Dyskinesia

Canada, United Kingdom
Novartis Pharmaceuticals

Completed

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia Agents

Spain, United States, Austria, Switzerland, France, Germany, Italy, Hungary, Canada, Slovakia
Novartis Pharmaceuticals

Completed

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia Agents

Spain, United States, Austria, Switzerland, France, Germany, Italy, Canada, Hungary, Slovakia
Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. (ALLAY-LID-I)

Parkinson's Disease | Levodopa Induced Dyskinesias (LID)

France, Spain, Germany, Canada, United States

Clinical Trials on Primary Ciliary Dyskinesia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations